• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study sheds light on how ‘dopamine neurons’ contribute to memory formation in humans

Bioengineer by Bioengineer
May 2, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Photo courtesy of the National Institutes of Health

LOS ANGELES — May 2, 2018 — Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.

A new study examined neurons that produce dopamine, a compound that acts as a transmitter for nerve impulses. It found that these dopamine neurons play a critical role in the formation of episodic memory, which allows people to remember such things as where they parked the car in the morning and what they had for dinner last night.

The study, published in the journal Current Biology, was co-authored by Ueli Rutishauser, PhD, the senior author and an associate professor in the Department of Neurosurgery at Cedars-Sinai. In the study, investigators observed the response of individual human dopamine neurons in patients undergoing deep brain stimulation surgery to treat Parkinson's disease. The patients watched a sequence of images: Some had never been seen before and were thus "novel"; others were repeated and were therefore "familiar."

For each image, the patient pressed a button indicating whether it was novel or familiar. This allowed investigators to track the formation of new memories, because an image was only novel once. Afterward, it formed a memory.

"What we discovered was that a subset of the dopaminergic neurons responded only when an image was novel, but not when it was familiar. In other words, it indicated if the image was new, but not if something was familiar," said Jan Kaminski, PhD, first author of the study and a project scientist at Cedars-Sinai. "This is an important new scientific discovery, because it has so far remained unclear how the dopaminergic system contributes to episodic memory formation."

This research was conducted while Parkinson's patients were having a deep brain stimulation device implanted to reduce their symptoms. As part of this procedure, during which patients are awake, an electrode is lowered into the brain to precisely localize the deep brain stimulation electrode. The target of the electrode is deep inside the brain, close to where the dopamine neurons are located.

"This procedure is one of the rare opportunities for researchers to observe the activity of dopamine neurons in an area of the brain called the substania nigra in an awake human being, a type of recording only possible because the patient is undergoing a neurosurgical procedure," said Adam Mamelak, MD, professor of Neurosurgery at Cedars-Sinai and a co-investigator of the study. "This setup provides extremely valuable new insights into how humans form memories."

While not directly tied to research on specific ailments, the findings provide new information relevant to the understanding of certain diseases, Rutishauser said. "Dopamine neurons degrade in neurodegenerative diseases such as Parkinson's, which in addition to motor symptoms is often also accompanied by cognitive issues such as memory problems," he said. "What this paper shows is that dopamine neurons activate for novel stimuli. This short 'burst' of dopamine is what triggers learning."

A common treatment for patients with Parkinson's, for instance, is to take medications that increase dopamine to a steady level. But those drugs do not facilitate the short bursts that help in the formation of memory. "Our work reveals new avenues for treatments that can be explored, including those that restore short bursts of dopamine or that otherwise increase activity analogous to what dopamine is thought to do," Rutishauser said.

Apart from the scientific insights derived, this study also is an excellent demonstration of the power of interdisciplinary research and collaboration. "The study team was composed of scientists, neurologists and neurosurgeons and was only possible due to a close collaboration between Neurosurgery and Neurology. This kind of team science is a perfect demonstration of the groundbreaking basic science made possible by the close integration between clinical and research work at Cedars-Sinai," said Keith Black, MD, chairman of the Department of Neurosurgery.

###

The study was supported by the Pfeiffer Foundation, NIH NINDS (U01NS098961), the NSF (BCS-1554105) and the McKnight Endowment Fund for Neuroscience.

DOI: 10.1016/j.cub.2018.03.024

Media Contact

Jonathan Diamond
[email protected]
323-866-8146
@cedarssinai

http://www.csmc.edu

Original Source

https://www.cedars-sinai.org/newsroom/study-sheds-light-on-how-dopamine-neurons-contribute-to-memory-formation-in-humans/ http://dx.doi.org/10.1016/j.cub.2018.03.024

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Unraveling EMT’s Role in Colorectal Cancer Spread

August 2, 2025
Gut γδ T17 Cells Drive Brain Inflammation via STING

Gut γδ T17 Cells Drive Brain Inflammation via STING

August 2, 2025

Agent-Based Framework for Assessing Environmental Exposures

August 2, 2025

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    38 shares
    Share 15 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling EMT’s Role in Colorectal Cancer Spread

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.